Ribalet B, Mirell C J, Johnson D G, Levin S R
Department of Physiology, University of California at Los Angeles, California 90024, USA.
J Gen Physiol. 1996 Feb;107(2):231-41. doi: 10.1085/jgp.107.2.231.
We have used hamster insulinoma tumor (HIT) cells, an insulin-secreting tumor cell line, to investigate modulation of the Na/K-ATPase and of the ATP-sensitive K channel (K(ATP)) by the sulfonylurea glyburide. Membrane proteins from cells cultured in RPMI with 11 mM glucose have at least two glyburide receptor populations, as evidenced by high and low binding affinity constants, (K(d) = 0.96 and 91 nM, respectively). In these cells K(ATP) channel activity was blocked by low glyburide concentrations, IC(50) = 5.4 nM. At 12.5 nM glyburide the inhibition developed slowly, tau = 380 s, and caused reduction of channel activity by 75 percent. At higher concentrations, however, inhibition occurred at a fast rate, tau = 42 s at 100 nM, and was almost complete. Na/K-ATPase activity measured enzymatically and electrophysiologically was also suppressed by glyburide, but higher concentrations were needed, IC(50) = 20-40 nM. Inhibition occurred rapidly, tau = 30 s at 50 nM, when maximum, activity was reduced by 40 percent. By contrast, cells cultured in RPMI supplemented with 25 mM glucose exhibit a single receptor population binding glyburide with low affinity, K(d)= 68 nM. In these cells inhibition of the Na/K-ATPase by the sulfonylurea was similar to that observed in cells cultured in 11 mM glucose, but K(ATP) channel inhibition was markedly altered. Inhibition occurred only at high concentrations of glyburide and at a fast rate; maximum inhibition was observed at 100 nM. Based on these data, we propose that glyburide binding to the high affinity site affects primarily K(ATP) channel activity, while interaction with the low affinity site inhibits both Na/K-ATPase and K(ATP) channel activities. The latter observation suggests possible functional interactions between the Na/K-ATPase and the K(ATP) channel.
我们利用仓鼠胰岛素瘤肿瘤(HIT)细胞(一种胰岛素分泌肿瘤细胞系)来研究磺脲类药物格列本脲对钠钾ATP酶和ATP敏感性钾通道(K(ATP))的调节作用。在含11 mM葡萄糖的RPMI培养基中培养的细胞的膜蛋白至少有两个格列本脲受体群体,高亲和力和低亲和力结合常数(K(d)分别为0.96和91 nM)证明了这一点。在这些细胞中,低浓度的格列本脲就能阻断K(ATP)通道活性,IC(50) = 5.4 nM。在12.5 nM格列本脲时,抑制作用发展缓慢,时间常数τ = 380秒,通道活性降低75%。然而,在较高浓度下,抑制作用迅速发生,在100 nM时时间常数τ = 42秒,且几乎完全抑制。通过酶法和电生理学方法测定的钠钾ATP酶活性也受到格列本脲的抑制,但需要更高的浓度,IC(50) = 20 - 40 nM。抑制作用迅速发生,在50 nM时时间常数τ = 30秒,最大活性降低40%。相比之下,在补充有25 mM葡萄糖的RPMI培养基中培养的细胞表现出单一的低亲和力格列本脲受体群体,K(d)= 68 nM。在这些细胞中,磺脲类药物对钠钾ATP酶的抑制作用与在含11 mM葡萄糖的培养基中培养的细胞中观察到的相似,但K(ATP)通道抑制作用明显改变。仅在高浓度的格列本脲时才会发生抑制作用,且抑制作用迅速;在100 nM时观察到最大抑制作用。基于这些数据,我们提出格列本脲与高亲和力位点结合主要影响K(ATP)通道活性,而与低亲和力位点相互作用则抑制钠钾ATP酶和K(ATP)通道活性。后一观察结果提示钠钾ATP酶和K(ATP)通道之间可能存在功能相互作用。